Figure 1. Study flowchart of children and adolescents enrolled in the study.

Figure 2. (A) SARS-CoV-2 viral load (copies/mL) in patients with [(+): green] and without [(−): red] nasopharyngeal symptoms. (B) Percentage of patients with (+) and without (−) nasopharyngeal symptoms displaying SARS-CoV-2 salivary viral load <105 and >105 copies/mL.

Table 1. Demographic and clinical characteristics of the enrolled subjects.

Table 1. Demographic and clinical characteristics of the enrolled subjects.

n (%)GenderMales17 (48.6) Females18 (51.4)Age, median (IQR) 8 (2–13)EthnicityWhite30 (85.7) Black3 (8.6) Hispanic2 (5.7)Need for hospitalizationYes8 (22.9) No27 (77.1)Prescribed therapyNone12 (34.3) Antipyretics20 (57.1) Antibiotics14 (40) Steroids9 (25.7)Referred symptoms at admissionNone8 (22.9) Fever22 (62.9) Dyspnea6 (17.1) Cough5 (14.3) Diarrhea/abdominal pain7 (20) Vomit6 (17.1) Asthenia1 (2.9) Headache3 (8.6) Rhinitis/pharyngodynia7 (20) Ageusia/anosmia0 (0) Exanthema4 (11.4) Conjunctivitis1 (2.9)